Methicillin-resistant Staphylococcus aureus colonization of the groin and risk for clinical infection among HIV-infected adults

Emerg Infect Dis. 2013 Apr;19(4):623-9. doi: 10.3201/eid1904.121353.

Abstract

Data on the interaction between methicillin-resistant Staphylococcus aureus (MRSA) colonization and clinical infection are limited. During 2007-2008, we enrolled HIV-infected adults in Atlanta, Georgia, USA, in a prospective cohort study. Nares and groin swab specimens were cultured for S. aureus at enrollment and after 6 and 12 months. MRSA colonization was detected in 13%-15% of HIV-infected participants (n=600, 98% male) at baseline, 6 months, and 12 months. MRSA colonization was detected in the nares only (41%), groin only (21%), and at both sites (38%). Over a median of 2.1 years of follow-up, 29 MRSA clinical infections occurred in 25 participants. In multivariate analysis, MRSA clinical infection was significantly associated with MRSA colonization of the groin (adjusted risk ratio 4.8) and a history of MRSA infection (adjusted risk ratio 3.1). MRSA prevention strategies that can effectively prevent or eliminate groin colonization are likely necessary to reduce clinical infections in this population.

Keywords: Georgia; HIV; MRSA; bacteria; colonization; methicillin-resistant Staphylococcus aureus; staphylococci; viruses.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Anti-HIV Agents / therapeutic use
  • Coinfection*
  • Georgia
  • Groin / microbiology*
  • HIV / drug effects
  • HIV / physiology*
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • Humans
  • Male
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / physiology*
  • Middle Aged
  • Nasal Cavity / microbiology
  • Prospective Studies
  • Risk Factors
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / prevention & control*

Substances

  • Anti-Bacterial Agents
  • Anti-HIV Agents